Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ALRT-1550 to enter clinical trials

Dec. 23, 1996

QLT signs European licensing agreement for photosensitizer

Dec. 23, 1996

LHRH antagonists under study at Takeda

Dec. 23, 1996

Schering-Plough claims novel use for Flt3 ligand

Dec. 23, 1996

Licensees sought for method of inducing CTL response

Dec. 20, 1996

Liposome formulation of cisplatin enters clinical trials

Dec. 20, 1996

Milestone reached in Genset-Synthelabo collaboration

Dec. 20, 1996

Mercian discovers other anthracycline antineoplastic agents

Dec. 20, 1996

Heterologous vectors for boosting antitumor immunity available for licensing

Dec. 19, 1996

Licensees sought for vector for polynucleotide vaccines

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....